Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo (Q33286995)

25 July 2017

title

Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo (English)

1 reference

25 July 2017

0 references

1 reference

C M Logar

1

1 reference

25 July 2017

P T Brinkkoetter

2

1 reference

25 July 2017

R D Krofft

3

1 reference

25 July 2017

J W Pippin

4

1 reference

25 July 2017

S J Shankland

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

6 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

72

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

489-498

1 reference

The erythropoietin receptor and its expression in tumor cells and other tissues

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Human, rat, and mouse kidney cells express functional erythropoietin receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Erythropoietin as an antiapoptotic, tissue-protective cytokine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Derivatives of erythropoietin that are tissue protective but not erythropoietic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Introduction to the podocyte issue: more than eight enigmas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Progression of glomerular diseases: is the podocyte the culprit?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Podocyte biology and response to injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Urinary excretion of podocytes in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Glomerular cell number in normal subjects and in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Podocytopenia and disease severity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: role of p53 and Bcl-2-related family proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Glomerular localization of erythropoietin receptor mRNA and protein in neonatal and mature mouse kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Attach first, then detach: a role for cyclin B-dependent kinase 1 in coordinating proteolysis with spindle assembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Apoptosis in podocytes induced by TGF-beta and Smad7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Recombinant human erythropoietin stimulates angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Limitation of podocyte proliferation improves renal function in experimental crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

The enhancement of aminonucleoside nephrosis by the co-administration of protamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Vascular endothelial growth factor and nephrin interact and reduce apoptosis in human podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Retinoids as a potential treatment for experimental puromycin-induced nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Update on erythropoietin treatment: should hemoglobin be normalized in patients with chronic kidney disease?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Optimization and standardization of the "comet assay" for analyzing the repair of DNA damage in cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5002362

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5002362

1 reference

Dimensions Publication ID

25 July 2017

1035641487

0 references

1 reference